Schedule 13G
IRWD Schedule 13G filing by Bank of America
Bank of America reported beneficial ownership of 12.0M shares, representing 7.4% of IRONWOOD PHARMACEUTICALS INC in this filing.
FiledNov 14, 2025
Ownership dateSep 30, 2025
Reported shares12.0M
Reported ownership7.4%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
0
Shared voting power
12.0M
Sole dispositive power
0
Shared dispositive power
12.0M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$3.14as of Nov 14, 2025
Latest tracked price$4.37as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Bank of America
- CIK
- CIK0000070858
- Accession
- 0000070858-25-000452
- Form
- Schedule 13G
Read the filing in context